Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2012
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120095062 Tricyclic compounds, compositions, and methods
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095022 Derivatives of 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-ones, method for preparation thereof and therapeutic uses thereof
04/19/2012US20120095020 Cathepsin S Inhibitor Compounds
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095010 Tricyclic delta-opioid modulators
04/19/2012US20120095006 Treatment of pulmonary hypertension
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095004 Sphingosine Kinase Inhibitors
04/19/2012US20120094996 Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives
04/19/2012US20120094990 Phenylacetic acid compound
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094976 New chemical compounds
04/19/2012US20120094975 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094966 Organic compounds
04/19/2012US20120094945 Discovery of Selective Glucocorticoid Receptor Modulators by Multiplexed Reporter Screening
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094942 Chemosensory Receptor Ligand-Based Therapies
04/19/2012US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
04/19/2012US20120094937 Mammalian cell surface antigens; related reagents
04/19/2012US20120094935 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094932 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094895 Method for enhancing phagocytosis of phosphatidylserine-exposing cells
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120094328 Fermentation product of cereal plant-derived material and immunomodulator
04/19/2012US20120093941 Neutrophil-depleted platelet rich plasma formulations for cardiac treatments
04/19/2012US20120093934 Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
04/19/2012US20120093921 Immunogenic compositions having low sodium chloride concentration
04/19/2012US20120093914 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone particles as scaffolds for tissue regeneration
04/19/2012US20120093891 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120093888 micro-emulsions for the treatment of rheumatic disorders
04/19/2012US20120093875 Aminocyclitol compounds, process for obtaining them and uses
04/19/2012US20120093874 Method for screening for diet providing production of milk having immunoregulatory action
04/19/2012US20120093873 Molecular Interactions in Hematopoietic Cells
04/19/2012US20120093872 Method For Polypeptide Transfer Into Cells
04/19/2012US20120093871 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
04/19/2012US20120093870 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto
04/19/2012US20120093868 Haemophilus influenzae type b
04/19/2012US20120093867 GNA1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis
04/19/2012US20120093865 Compositions comprising reduced genome bacteria for use in treatment of sepsis
04/19/2012US20120093864 Methods and Compositions for Polytopic Vaccination
04/19/2012US20120093861 Norovirus vaccine formulations
04/19/2012US20120093860 Influenza vaccines with increased amounts of h3 antigen
04/19/2012US20120093859 Influenza vaccine regimens for pandemic-associated strains
04/19/2012US20120093858 Tat-Based Tolerogen Compositions and Methods for Making and Using Same
04/19/2012US20120093856 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
04/19/2012US20120093855 RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF
04/19/2012US20120093854 Use of mycoplasma bovis antigen
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093852 Non-lipidated variants of neisseria meningitidis orf2086 antigens
04/19/2012US20120093851 Chlamydia antigens
04/19/2012US20120093850 Compositions for immunising against staphylococcus aureus
04/19/2012US20120093848 Immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
04/19/2012US20120093847 Recombinant rsv vaccines
04/19/2012US20120093846 Protein for the immunocastration for mammals
04/19/2012US20120093845 Neil3 peptides and vaccines including the same
04/19/2012US20120093844 Antimicrobial peptides based on cmap27
04/19/2012US20120093834 Neutralizing molecules to viral antigens
04/19/2012US20120093830 Single domain antibodies that bind il-13
04/19/2012US20120093829 New methods for treatment of inflammatory diseases
04/19/2012US20120093828 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
04/19/2012US20120093827 Treatment of autoimmune disorders with a neurotoxin
04/19/2012US20120093821 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
04/19/2012US20120093820 Prostatitis-Associated Antigens and Methods of Use Thereof
04/19/2012US20120093804 Concatamers for Immunemodulation
04/19/2012US20120093802 Bioactive composition including stabilized protein and process for producing the same
04/19/2012US20120093796 Novel use of ec-sod and method for preparing thereof
04/19/2012US20120093793 Methods of Preventing Platelet Alloimmunization and Alloimmune Platelet Refractoriness and Induction of Tolerance in Transfused Recipients
04/19/2012US20120093792 Immunotherapy for pancreatic cancer
04/19/2012US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/19/2012US20120093761 Vaccine compositions and methods of use thereof
04/19/2012US20120091605 Chewable Soft Capsule
04/19/2012CA2814673A1 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay
04/19/2012CA2814431A1 Therapies for improving pulmonary function
04/19/2012CA2814176A1 Methods and compositions for inducing a t-cell response to plasmodium species
04/19/2012CA2814011A1 Salts of arylsulfonamide ccr3 antagonists
04/19/2012CA2813344A1 Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
04/19/2012CA2812779A1 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
04/19/2012CA2799442A1 Bacterial ribonucleic acid cell wall compositions and methods of making and using them
04/18/2012EP2441762A1 Potentiators of Glutamate Receptors
04/18/2012EP2441443A1 Lactoferrin based complex coacervates and their uses
04/18/2012EP2440582A2 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
04/18/2012EP2440554A1 Pyrazole oxadiazole derivatives as s1p1 agonists
04/18/2012EP2440536A1 Oxazole and thiazole derivatives as alx receptor agonists
04/18/2012EP2440529A1 Janus kinase inhibitor compounds and methods
04/18/2012EP2440251A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
04/18/2012EP2440246A2 Egfr and par2 regulation of intestinal permeability
04/18/2012EP2440244A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
04/18/2012EP2440238A1 Methods of treatment
04/18/2012EP2440054A1 Pyridil-triazine inhibitors of hedgehog signaling
04/18/2012EP2197477B1 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 1172